Clinical Trials Logo

Clinical Trial Details — Status: Recruiting

Administrative data

NCT number NCT03144921
Other study ID # STUDY00005510, STUDY00012907
Secondary ID
Status Recruiting
Phase N/A
First received
Last updated
Start date December 12, 2017
Est. completion date May 2024

Study information

Verified date May 2023
Source Arizona State University
Contact Coon Research Team
Phone 602-496-1239
Email coonresearch@asu.edu
Is FDA regulated No
Health authority
Study type Interventional

Clinical Trial Summary

EPIC II (Early-Stage Partners in Care) is a research project designed to assist people with early-stage memory loss and their care partners by providing early-stage related education and skill-training sessions, held via Zoom, designed to reduce stress, enhance well-being, manage challenges, and plan for the future. Researchers will gather feedback from individuals about their experience to continue to improve programs for early-stage memory loss.


Description:

The purpose of this study is to help early-stage individuals who have early-stage memory loss or early stage dementia and their current or future care partners by providing education and skill-training programs, held via Zoom, designed to reduce stress and distress, increase well-being and quality of life, and plan for the future. About 160 early-stage dyads (person with early-stage dementia and his/her care partner) will be enrolled across the United States through Arizona State University. People who decide to voluntarily participate in this program, will be asked to: - Meet others with memory loss and their care partners. - Attend six group sessions via Zoom (2 hours & 30 minutes each) to learn strategies to help handle new situations, reduce stress, improve mood, communicate better with each other, and plan for the future. - Participate in one 90-minute individualized session via Zoom to address specific issues that may be unique to each dyad's situation. - Participate in three 2-hour confidential interviews that involve questions about background, mood, and quality of life. - Participate in interviews at the start, and again about 3 and 6 months, via Zoom, to help us to continue to improve the program. - Attend several monthly booster sessions after completion of the seven EPIC sessions. Each person will receive up to $45 for completing all follow-up interviews, or $20- 25 for each interview completed. All participants are offered the EPIC sessions shortly after their first interview or shortly after their 3-month interview. Some participants will also attend an additional free education workshop within one month of the initial assessment.


Recruitment information / eligibility

Status Recruiting
Enrollment 320
Est. completion date May 2024
Est. primary completion date May 2024
Accepts healthy volunteers Accepts Healthy Volunteers
Gender All
Age group 18 Years and older
Eligibility DYAD INCLUSION CRITERIA: 1. All participants - Care Partners (CP) and Early-Stage People (EP) - will be at least 18 years of age and speak, read, and write English or Spanish. 2. Eligible dyad relationships include spouse, adult-child relationships (e.g., daughters), and other close friends and family members. 3. Care partners must self-identify as the person who currently has or who expects to have the most hands-on responsibility and ongoing involvement with the EP. 4. CPs must live with or have regular contact with the EP. 5. EPs and CPs must reside in a community setting. EP INCLUSION CRITERIA: 1. Live at home rather than an institutional setting, 2. Have a confirmed diagnosis of OR symptoms consistent with early-stage dementia 3. Exhibit changes in memory as specified on the AD8 dementia screening tool. 4. Have a Mini-Mental State Exam (MMSE)i score within a protocol-specified range. 5. Have a CP who is defined by the EP as being the unpaid "family member" who has or will have primary responsibility for providing assistance to the EP EP EXCLUSION CRITERIA: 1. Denying or not reporting any trouble with memory, based on self-report 2. Normal cognition, based on score derived from screening tool 3. If yes to BOTH: 1. severe mental illness or developmental disability before the age of 45 2. memory problems due to past head injury

Study Design


Related Conditions & MeSH terms


Intervention

Behavioral:
psychoeducational skills training intervention
This protocol is a minimal risk care values clarification /care planning and psychoeducational skills training intervention, delivered as a workshop series plus one in-home session for people in the early stages of memory loss and their care partner together.

Locations

Country Name City State
United States Nationwide Program Locations (Based at ASU Edson College of Nursing and Health Innovation) Phoenix Arizona

Sponsors (1)

Lead Sponsor Collaborator
Arizona State University

Country where clinical trial is conducted

United States, 

Outcome

Type Measure Description Time frame Safety issue
Other Initial incremental cost effectiveness of EPIC compared with Wait List Comparison condition Based on Quality of Life Adjusted Years for the EPs and hours providing care for CPs, conduct a cost benefit analysis to explicitly indicate whether benefits of the EPIC program outweigh costs by looking at the change over time. T1 - T2 Assessments (Baseline to 3 months)
Primary EP and CP Emotional well-being Examine the efficacy of the EPIC intervention as compared with a Wait List Comparison condition by looking at the change over time in the Positive and Negative Affect Scales (Dementia Quality of Life Instrument). Assessments T1-T3 to be conducted over span of six months
Primary EP Quality of Life Assess EP Quality of life and CPs perception of EPs Quality of life by looking at the change over time in the Quality of Life Measure in Dementia. Assessments T1-T3 to be conducted over span of six months
Secondary Knowledge and Use of Services for People with Dementia and their Care Partners Assess the knowledge of, use of, and satisfaction with a variety of services (for example, respite, support groups, case management, referral services) relevant to people with dementia and their care partners by looking at the change over time. Assessments T1-T3 to be conducted over span of six months
Secondary Communication Skills and Support within the Dyad Assess communication by looking at the change over time in the Dyadic Relationship Scale and Emotional Intimacy Disruptive Behavior Scale. Assessments T1-T3 to be conducted over span of six months
Secondary EP and CP Care preparedness Assess EP and CP perceptions of how well prepared they feel for addressing future care needs by looking at the change over time in the Care Partners Preparedness Scale (modified). Assessments T1-T3 to be conducted over span of six months
See also
  Status Clinical Trial Phase
Completed NCT04044495 - Sleep, Rhythms and Risk of Alzheimer's Disease N/A
Completed NCT04079803 - PTI-125 for Mild-to-moderate Alzheimer's Disease Patients Phase 2
Terminated NCT03052712 - Validation and Standardization of a Battery Evaluation of the Socio-emotional Functions in Various Neurological Pathologies N/A
Recruiting NCT04520698 - Utilizing Palliative Leaders In Facilities to Transform Care for Alzheimer's Disease N/A
Active, not recruiting NCT04606420 - Can Lifestyle Changes Reverse Early-Stage Alzheimer's Disease N/A
Recruiting NCT05820919 - Enhancing Sleep Quality for Nursing Home Residents With Dementia - R33 Phase N/A
Terminated NCT03672474 - REGEnLIFE RGn530 - Feasibility Pilot N/A
Completed NCT03430648 - Is Tau Protein Linked to Mobility Function?
Recruiting NCT04949750 - Efficacy of Paper-based Cognitive Training in Vietnamese Patients With Early Alzheimer's Disease N/A
Recruiting NCT05288842 - Tanycytes in Alzheimer's Disease and Frontotemporal Dementia
Recruiting NCT05557409 - A Study to Assess the Efficacy and Safety of AXS-05 in Subjects With Alzheimer's Disease Agitation Phase 3
Recruiting NCT04522739 - Spironolactone Safety in African Americans With Mild Cognitive Impairment and Early Alzheimer's Disease Phase 4
Completed NCT06194552 - A Multiple Dose Study of the Safety and Pharmacokinetics of NTRX-07 Phase 1
Completed NCT03239561 - Evaluation of Tau Protein in the Brain of Participants With Alzheimer's Disease Compared to Healthy Participants Early Phase 1
Completed NCT03184467 - Clinical Trial to Evaluate the Efficacy and Safety of GV1001 in Alzheimer Patients Phase 2
Active, not recruiting NCT03676881 - Longitudinal Validation of a Computerized Cognitive Battery (Cognigram) in the Diagnosis of Mild Cognitive Impairment and Alzheimer's Disease
Terminated NCT03487380 - Taxonomic and Functional Composition of the Intestinal Microbiome: a Predictor of Rapid Cognitive Decline in Patients With Alzheimer's Disease N/A
Completed NCT05538455 - Investigating ProCare4Life Impact on Quality of Life of Elderly Subjects With Neurodegenerative Diseases N/A
Recruiting NCT05328115 - A Study on the Safety, Tolerability and Immunogenicity of ALZ-101 in Participants With Early Alzheimer's Disease Phase 1
Completed NCT05562583 - SAGE-LEAF: Reducing Burden in Alzheimer's Disease Caregivers Through Positive Emotion Regulation and Virtual Support N/A